Vita Life Sciences Ltd
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands… Read more
Vita Life Sciences Ltd (VLS) - Total Assets
Latest total assets as of June 2025: AU$74.64 Million AUD
Based on the latest financial reports, Vita Life Sciences Ltd (VLS) holds total assets worth AU$74.64 Million AUD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Vita Life Sciences Ltd - Total Assets Trend (2000–2024)
This chart illustrates how Vita Life Sciences Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Vita Life Sciences Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Vita Life Sciences Ltd's total assets of AU$74.64 Million consist of 81.9% current assets and 18.1% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 39.8% |
| Accounts Receivable | AU$12.00 Million | 16.7% |
| Inventory | AU$16.60 Million | 23.1% |
| Property, Plant & Equipment | AU$10.33 Million | 14.4% |
| Intangible Assets | AU$50.00K | 0.1% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Vita Life Sciences Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vita Life Sciences Ltd's current assets represent 81.9% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 39.8% of total assets in 2024, up from 7.9% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 18.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 23.1% of total assets.
Vita Life Sciences Ltd Competitors by Total Assets
Key competitors of Vita Life Sciences Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Vita Life Sciences Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Vita Life Sciences Ltd generates 1.11x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Vita Life Sciences Ltd generates $ 12.22 in net profit.
Vita Life Sciences Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.94 | 2.96 | 2.17 |
| Quick Ratio | 2.21 | 2.18 | 1.58 |
| Cash Ratio | 1.46 | 1.46 | 1.04 |
| Working Capital | AU$39.07 Million | AU$ 37.24 Million | AU$ 14.77 Million |
Vita Life Sciences Ltd - Advanced Valuation Insights
This section examines the relationship between Vita Life Sciences Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.69 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | 20.2% |
| Total Assets | AU$71.89 Million |
| Market Capitalization | $31.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Vita Life Sciences Ltd's assets below their book value (0.43 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Vita Life Sciences Ltd's assets grew by 20.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Vita Life Sciences Ltd (2000–2024)
The table below shows the annual total assets of Vita Life Sciences Ltd from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$71.89 Million | +20.21% |
| 2023-12-31 | AU$59.81 Million | +15.46% |
| 2022-12-31 | AU$51.80 Million | +14.42% |
| 2021-12-31 | AU$45.27 Million | +15.77% |
| 2020-12-31 | AU$39.10 Million | +7.10% |
| 2019-12-31 | AU$36.51 Million | +2.22% |
| 2018-12-31 | AU$35.72 Million | +8.39% |
| 2017-12-31 | AU$32.95 Million | +1.84% |
| 2016-12-31 | AU$32.36 Million | -0.09% |
| 2015-12-31 | AU$32.39 Million | +6.99% |
| 2014-12-31 | AU$30.27 Million | +37.54% |
| 2013-12-31 | AU$22.01 Million | +30.90% |
| 2012-12-31 | AU$16.81 Million | +25.95% |
| 2011-12-31 | AU$13.35 Million | -8.01% |
| 2010-12-31 | AU$14.51 Million | +64.72% |
| 2009-12-31 | AU$8.81 Million | +1.96% |
| 2008-12-31 | AU$8.64 Million | +28.41% |
| 2007-12-31 | AU$6.73 Million | -47.06% |
| 2006-12-31 | AU$12.71 Million | -20.30% |
| 2005-12-31 | AU$15.95 Million | -16.11% |
| 2004-12-31 | AU$19.01 Million | -2.99% |
| 2003-12-31 | AU$19.60 Million | -42.61% |
| 2002-12-31 | AU$34.15 Million | -48.30% |
| 2001-12-31 | AU$66.05 Million | +34.94% |
| 2000-12-31 | AU$48.95 Million | -- |